Related Experiment Video

Updated: Aug 9, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Uric acid and cardiovascular risk

Michael H Alderman1

  • 1Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA. alderman@aecom.yu.edu

Current Opinion in Pharmacology
|April 16, 2002
PubMed

Insights

High serum uric acid levels are strongly linked to cardiovascular disease risk, morbidity, and mortality, especially in patients with hypertension or diabetes. However, current evidence does not confirm a causal relationship.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Epidemiology

Background:

  • Serum uric acid is a known risk factor for cardiovascular disease (CVD).
  • Epidemiological studies consistently show a graded association between uric acid levels and CVD morbidity/mortality.
  • This association is particularly pronounced in high-risk populations, including those with hypertension, diabetes, and congestive heart failure.

Purpose of the Study:

  • To review the epidemiological evidence linking serum uric acid levels to cardiovascular disease.
  • To explore potential mechanisms underlying this association.
  • To assess the current evidence regarding a causal or reversible relationship between uric acid and vascular disease.

Main Methods:

  • Systematic review of epidemiological studies.
  • Analysis of data from diverse patient cohorts, including those with pre-existing cardiovascular risk factors.
  • Evaluation of proposed pathophysiological mechanisms.

Main Results:

  • A significant, graded, independent, and specific association exists between serum uric acid levels and cardiovascular morbidity and mortality.
  • This association is robust in individuals with hypertension, diabetes, and congestive heart failure.
  • Several potential mechanisms linking uric acid to vascular disease have been proposed.

Conclusions:

  • Serum uric acid is a significant independent predictor of cardiovascular disease.
  • While associations are strong, particularly in high-risk groups, evidence for a causal or reversible role of uric acid in vascular disease remains inconclusive.
  • Further research is needed to elucidate the precise role of uric acid in cardiovascular pathophysiology.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...